We hypothesized that in the krasV12 transgenic model, oncogenic hepatocytes develop NASH by accumulating triglycerides, which are converted to bile acids by Cholesterol 7 alpha-hydroxylase (Cyp7a1), the main enzyme in the classical pathway of bile acid synthesis48. This evidence concerns the gene CYP7A1 and metabolic dysfunction-associated steatohepatitis.